Boston Financial Mangement LLC cut its position in shares of Danaher Corporation (NYSE:DHR) by 10.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 65,971 shares of the conglomerate’s stock after selling 7,624 shares during the quarter. Boston Financial Mangement LLC’s holdings in Danaher Corporation were worth $5,659,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. GQG Partners LLC acquired a new position in shares of Danaher Corporation in the 2nd quarter worth $101,000. Proficio Capital Partners LLC grew its holdings in shares of Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares during the last quarter. Monetary Management Group Inc. grew its holdings in shares of Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares during the last quarter. Acrospire Investment Management LLC grew its holdings in shares of Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares during the last quarter. Finally, ClariVest Asset Management LLC acquired a new position in shares of Danaher Corporation in the 1st quarter worth $157,000. Institutional investors own 75.38% of the company’s stock.
In other news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher Corporation stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the transaction, the chief executive officer now directly owns 271,737 shares in the company, valued at $25,173,715.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Daniel L. Comas sold 88,184 shares of Danaher Corporation stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.02, for a total value of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares in the company, valued at $20,735,812.32. The disclosure for this sale can be found here. Insiders sold 317,498 shares of company stock valued at $28,838,801 in the last ninety days. Insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (NYSE DHR) opened at $93.30 on Friday. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $93.86. The firm has a market capitalization of $65,090.00, a PE ratio of 23.96, a price-to-earnings-growth ratio of 2.22 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the previous year, the firm earned $0.87 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. sell-side analysts expect that Danaher Corporation will post 3.99 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. Danaher Corporation’s dividend payout ratio is currently 16.67%.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://sportsperspectives.com/2017/11/18/danaher-corporation-dhr-shares-sold-by-boston-financial-mangement-llc.html.
A number of equities analysts recently issued reports on DHR shares. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation presently has a consensus rating of “Buy” and a consensus target price of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.